Browse
Submit Data
Databases
API
Help

Dataset Information

21 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

2-Amino-4-(4-bromo-phen-yl)-8-trifluoro-methyl-3,4-dihydropyrimido[1,2-a][1,3,5]triazin-6(5H)-one.

ABSTRACT: The title compound, C(13)H(9)BrF(3)N(5)O, crystallizes with two independent mol-ecules in the asymmetric unit. The pyrimidine rings of the mol-ecules are planar [maximum deviations 0.053?(3) and 0.012?(3)?Å], while the triazine rings adopt flattened half-boat conformations with the p-bromo-phenyl rings in the flagpole positions. The crystal packing is stabilized by a three-dimensional network of inter-molecular N-H?N, N-H?O and N-H?F hydrogen bonds.

SUBMITTER: Dolzhenko AV

PROVIDER: S-EPMC2969032 | biostudies-literature | 2009 Mar

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

2-Amino-4-(4-bromo-phen-yl)-8-trifluoro-methyl-3,4-dihydropyrimido[1,2-a][1,3,5]triazin-6(5H)-one.

Dolzhenko Anton V AV Sachdeva Nikhil N Tan Geok Kheng GK Koh Lip Lin LL Chui Wai Keung WK

Acta crystallographica. Section E, Structure reports online 20090306 Pt 4

The title compound, C(13)H(9)BrF(3)N(5)O, crystallizes with two independent mol-ecules in the asymmetric unit. The pyrimidine rings of the mol-ecules are planar [maximum deviations 0.053 (3) and 0.012 (3) Å], while the triazine rings adopt flattened half-boat conformations with the p-bromo-phenyl rings in the flagpole positions. The crystal packing is stabilized by a three-dimensional network of inter-molecular N-H⋯N, N-H⋯O and N-H⋯F hydrogen bonds. ...[more]

PMID: 21582426

Similar Datasets

1,3,5-Tris(4-bromo-phen-yl)-1,3,5-triazin-ane di-chloro-methane monosolvate.

Project description:In the main mol-ecule of the title compound, C21H18Br3N3·CH2Cl2, the triazinane ring adopts a chair conformation with three 4-brom-ophenyl substituents, two in diaxial positions and the third in an equatorial arrangement (eaa). The torsion angles around the N-C bonds in the triazinane ring are in the range 55.6?(5)-60.1?(5)°. The structure can be described as being built up of alternating layers along the b axis with the CH2Cl2 solvent mol-ecules sandwiched between these layers. No classical hydrogen-bonding inter-actions are observed in the crystal structure.

| S-EPMC3685111 | biostudies-literature

4-Amino-2,8-dimethyl-6H-pyrimido[1,2-a][1,3,5]triazin-6-one.

Project description:In the title compound, C(8)H(9)N(5)O, the mean planes through the pyrimidine and triazine rings form a dihedral angle of 2.83?(16)°. The amino group adopts a trigonal-planar configuration and forms an intra-molecular resonance-assisted N-H?O=C hydrogen bond with the carbonyl group. In the crystal, mol-ecules are linked via inter-molecular N-H?N hydrogen bonds into chains of C(2) (2)(6)[R(2) (2)(6)] motif. The molecules form two types of sheet parallel to (201) and (01), respectively.

| S-EPMC3007556 | biostudies-literature

5-Methyl-3,6,7,8a-tetra-hydro-2H-diimidazo[1,2-c:1',2'-e]pyrido[1,2-a][1,3,5]triazin-5-ium iodide.

Project description:The structure of the title compound, C(12)H(16)N(5) (+)·I(-), shows that the methyl-ation reaction with CH(3)I occurred at the imine N atom at position 5 of the 3,6,7,8a-tetra-hydro-2H-diimidazo[1,2-c:1',2'-e]pyrido[1,2-a][1,3,5]triazine system. In the cation, the sp(3)-hybridized C atom belonging to the fused dihydro-pyrine and dihydro-1,3,5-triazine rings deviates by 0.514?(3)?Å from the best plane defined by the remaining cationic non-H atoms. The fused dihydro-pyridine and dihydro-1,3,5-triazine rings are each in a half-chair conformation with the sp(3)-hybridized C atom as a flap. The iodide anion is 3.573?(2)?Å from the methyl-ated N atom and exhibits five short C-H?I(-) contacts with distances less than 3.16?Å. The structure has been determined from a non-merohedral twin with twin law [-1 0 0 0 - 1 0 0.115 0 1], minor domain = 0.1559?(12).

| S-EPMC2979596 | biostudies-literature

5,7-Dibromo-3-trifluoro-methyl-3,4-dihydro-acridin-1(2H)-one.

Project description:In the title compound, C(14)H(8)Br(2)F(3)NO, the mol-ecule is disordered across an approximate non-crystallographic mirror plane, which is in the plane of the fused ring system [The tetrahedral C atom bearing the trifluormethyl substituent is disordered with site occupancy factors of 0.80?(2) and 0.20?(2)]. In the crystal, a one-dimensional stacking of mol-ecules involves inter-actions between the pyridine ring and symmetry-related Br and O atoms of adjacent mol-ecules. The stacking distance between the mean planes of adjacent mol-ecules is 3.395?(4)?Å.

| S-EPMC3213499 | biostudies-literature

(E)-1,2-Bis(3-bromo-4-methyl-phen-yl)ethene.

Project description:In the structure of the title compound, C(16)H(14)Br(2), the central C=C bond length is 1.329?(4)?Å and the two benzene rings are approximately coplanar with the double bond, with twist angles of 7.5?(2) and 13.6?(2)°.

| S-EPMC2960391 | biostudies-literature

2,4-Diamino-6-methyl-1,3,5-triazin-1-ium nitrate.

Project description:In the title salt, C(4)H(8)N(5) (+)·NO(3) (-), a ring N atom of 2,6-diamino-4-methyl-triazine is protonated. Each anion is connected to three neighbouring cations by multiple N-H?O hydrogen bonds which, together with N-H?N contacts, generate a layer structure.

| S-EPMC2968528 | biostudies-literature

2-Phenyl-7-(4-pyridyl-methyl-amino)-1,2,4-triazolo[1,5-a][1,3,5]triazin-5(4H)-one.

Project description:In the title compound, C(16)H(13)N(7)O, the 1,2,4-triazolo[1,5-a][1,3,5]triazine heterocyclic system is essentially planar (r.m.s. deviation = 0.0375?Å). The attached benzene ring lies almost in the mean plane of 1,2,4-triazolo[1,5-a][1,3,5]triazine [dihedral angle = 1.36?(23)°], while the pyridine ring is turned out of this plane by the amino-methyl bridge [dihedral angle = 69.22?(9)°]. The amino group H atom is involved in intra-molecular hydrogen bonding with a triazole N atom. In the crystal, mol-ecules are connected via C(=O)NH?N hydrogen bonds into C(11) chains parallel to [100]. The amino group H atom acts as a hydrogen-bond donor, forming an NH?O=C hydrogen bond with the carbonyl O atom, which links the mol-ecules into C(6) chains running along [011] and [01].

| S-EPMC3050179 | biostudies-literature

9-(2-Bromo-phen-oxy-carbon-yl)-10-methyl-acridinium trifluoro-methane-sulfonate.

Project description:In the crystal structure of the title compound, C(21)H(15)BrNO(2) (+)·CF(3)SO(3) (-), adjacent cations are linked through C-Br?? and ?-? contacts [centroid-centroid distance = 3.744?(2)?Å], and neighbouring cations and anions via C-H?O, C-F?? and S-O?? inter-actions. The acridine and benzene ring systems are oriented at a dihedral angle of 18.7?(1)°. The carb-oxy group is twisted at an angle of 69.3?(1)° relative to the acridine skeleton. The mean planes of adjacent acridine moieties are either parallel or inclined at an angle of 27.8?(1)° in the lattice.

| S-EPMC3379313 | biostudies-literature

3-(4-Bromo-phen-yl)-4-[2-(4-nitro-phen-yl)hydrazin-yl]furan-2(5H)-one.

Project description:In the title compound, C(16)H(12)BrN(3)O(4), the furan-2(5H)-one ring forms a dihedral angle of 33.19?(9)° with the 4-bromo-benzene unit and is nearly perpendicular to the 4-nitro-benzene segment, making a dihedral angle of 89.93?(10)°. In the crystal, N-H?O hydrogen bonds link the mol-ecules, generating an infinite chain along [010]. The chains are linked into a three-dimensional network by C-H?O, C-H?? and ?-? contacts [centroid-centroid separation = 3.805?(2)?Å].

| S-EPMC3247473 | biostudies-literature

3-(4-Bromo-phen-yl)-4-(4-hy-droxy-anilino)furan-2(5H)-one.

Project description:In the title compound, C(16)H(12)BrNO(3), the butyrolactone core adopts the furan-2(5H)-one structure and forms dihedral angles of 44.80 (17) and 65.73 (18)° with the bromo-benzene and phenol rings, respectively. In the crystal, N-H⋯O and O-H⋯O hydrogen bonds link the mol-ecules, generating R(4) (3)(26) loops The edge-fused rings extend to form a chain running along the b-axis direction and C-H⋯π contacts help to consolidate the packing.

| S-EPMC3200956 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data